IMBdx

Our Solution

Early detection of cancer.

Presentations

게시물 목록
NO	YEAR	SUBJECT	JOURNAL NAME	LINK
18	2025	Clinical Utility of Circulating Tumor DNA for Tumor Profiling and Monitoring in High-Grade Serous Ovarian Cancer Clinical Utility of Circulating Tumor DNA for Tumor Profiling and Monitoring in High-Grade Serous Ovarian Cancer AACR-KCA Profiling Clinical Utility of Circulating Tumor DNA for Tumor Profiling and Monitoring in High-Grade Serous Ovarian Cancer	AACR-KCA
17	2025	Performance of a tissue-agnostic approach based on whole-genome methylation and fragmentomics features for detecting minimal residual disease (MRD) in colorectal cancer (CRC) and its comparison with a clinically validated, tissue-informed Performance of a tissue-agnostic approach based on whole-genome methylation and fragmentomics features for detecting minimal residual disease (MRD) in colorectal cancer (CRC) and its comparison with a clinically validated, tissue-informed MRD assay European Society for Medical Oncology (ESMO) MRD monitoring Performance of a tissue-agnostic approach based on whole-genome methylation and fragmentomics features for detecting minimal residual disease (MRD) in colorectal cancer (CRC) and its comparison with a clinically validated, tissue-informed	European Society for Medical Oncology (ESMO)
16	2025	"Utilizing cfDNA Fragment Traits to Identify CHIP in Canonical and Non-Canonical Genes with Machine Learning" Utilizing cfDNA Fragment Traits to Identify CHIP in Canonical and Non-Canonical Genes with Machine Learning JCA-AACR Profiling "Utilizing cfDNA Fragment Traits to Identify CHIP in Canonical and Non-Canonical Genes with Machine Learning"	JCA-AACR
15	2025	Postoperative Minimal Residual Disease Detection Using Tumor-Informed Circulating Tumor DNA Analysis in Stage II-III Gastric Cancer Postoperative Minimal Residual Disease Detection Using Tumor-Informed Circulating Tumor DNA Analysis in Stage II-III Gastric Cancer American Assoiation for Cancer Research (AACR) MRD monitoring Postoperative Minimal Residual Disease Detection Using Tumor-Informed Circulating Tumor DNA Analysis in Stage II-III Gastric Cancer	American Assoiation for Cancer Research (AACR)
14	2025	Preliminary Results of Perioperative Minimal Residual Disease Monitoring Using a Tumor-informed ctDNA Assay in Stage II-III Breast Cancer Preliminary Results of Perioperative Minimal Residual Disease Monitoring Using a Tumor-informed ctDNA Assay in Stage II-III Breast Cancer American Assoiation for Cancer Research (AACR) MRD monitoring Preliminary Results of Perioperative Minimal Residual Disease Monitoring Using a Tumor-informed ctDNA Assay in Stage II-III Breast Cancer	American Assoiation for Cancer Research (AACR)